Literature DB >> 15002459

Desert docs.

Paul Keeley.   

Abstract

Mesh：

Year:  2003        PMID： 15002459      PMCID： PMC1314766     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  10 in total

1.  Medicalisation, limits to medicine, or never enough money to go around?

Authors:  Nick Freemantle; Suzanne Hill
Journal:  BMJ       Date:  2002-04-13

Review 2.  Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors:  Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

Review 3.  The making of a disease: female sexual dysfunction.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2003-01-04

4.  The new GMS contract--a Trojan horse?

Authors:  Shamini Gnani; Allyson M Pollock
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

5.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

6.  Studies on shingles: is the virus ordinary chickenpox virus?

Authors:  R E H SIMPSON
Journal:  Lancet       Date:  1954-12-25       Impact factor: 79.321

7.  Deprivation payments and workload.

Authors:  D Hannay
Journal:  Br J Gen Pract       Date:  1997-10       Impact factor: 5.386

8.  Identification of underprivileged areas.

Authors:  B Jarman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

9.  Primary non-compliance with prescribed medication in primary care.

Authors:  P H Beardon; M M McGilchrist; A D McKendrick; D G McDevitt; T M MacDonald
Journal:  BMJ       Date:  1993-10-02

10.  Quality measurement of care for people with type 2 diabetes in Tayside, Scotland: implications for the new UK general practice contract.

Authors:  Bruce Guthrie; Alistair Emslie-Smith; Andrew Morris; Tom Fahey; Frank Sullivan
Journal:  Br J Gen Pract       Date:  2003-09       Impact factor: 5.386
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.